These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27581750)

  • 1. Sharing success - understanding barriers and enablers to secondary prophylaxis delivery for rheumatic fever and rheumatic heart disease.
    Chamberlain-Salaun J; Mills J; Kevat PM; Rémond MG; Maguire GP
    BMC Cardiovasc Disord; 2016 Aug; 16(1):166. PubMed ID: 27581750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in rheumatic fever and rheumatic heart disease management and prevention using a health centre-based continuous quality improvement approach.
    Ralph AP; Fittock M; Schultz R; Thompson D; Dowden M; Clemens T; Parnaby MG; Clark M; McDonald MI; Edwards KN; Carapetis JR; Bailie RS
    BMC Health Serv Res; 2013 Dec; 13():525. PubMed ID: 24350582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A qualitative examination of secondary prophylaxis in rheumatic heart disease: factors influencing adherence to secondary prophylaxis in Uganda.
    Huck DM; Nalubwama H; Longenecker CT; Frank SH; Okello E; Webel AR
    Glob Heart; 2015 Mar; 10(1):63-69.e1. PubMed ID: 25754568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving Delivery of Secondary Prophylaxis for Rheumatic Heart Disease in a High-Burden Setting: Outcome of a Stepped-Wedge, Community, Randomized Trial.
    Ralph AP; de Dassel JL; Kirby A; Read C; Mitchell AG; Maguire GP; Currie BJ; Bailie RS; Johnston V; Carapetis JR
    J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 30018165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic penicillin by the full moon: a novel approach in Central Australia that may help to reduce the risk of rheumatic heart disease.
    Kearns TM; Schultz R; McDonald V; Andrews RM
    Rural Remote Health; 2010; 10(3):1464. PubMed ID: 20795756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence rates and risk factors for suboptimal adherence to secondary prophylaxis for rheumatic fever.
    Kevat PM; Gunnarsson R; Reeves BM; Ruben AR
    J Paediatr Child Health; 2021 Mar; 57(3):419-424. PubMed ID: 33340191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approaches to Improving Adherence to Secondary Prophylaxis for Rheumatic Fever and Rheumatic Heart Disease: A Literature Review with a Global Perspective.
    Rémond MG; Coyle ME; Mills JE; Maguire GP
    Cardiol Rev; 2016; 24(2):94-8. PubMed ID: 25807106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary consultation on preferred product characteristics of benzathine penicillin G for secondary prophylaxis of rheumatic fever.
    Wyber R; Boyd BJ; Colquhoun S; Currie BJ; Engel M; Kado J; Karthikeyan G; Sullivan M; Saxena A; Sheel M; Steer A; Mucumbitsi J; Zühlke L; Carapetis J
    Drug Deliv Transl Res; 2016 Oct; 6(5):572-8. PubMed ID: 27465618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Priorities for improved management of acute rheumatic fever and rheumatic heart disease: analysis of cross-sectional continuous quality improvement data in Aboriginal primary healthcare centres in Australia.
    Katzenellenbogen JM; Bond-Smith D; Ralph AP; Wilmot M; Marsh J; Bailie R; Matthews V
    Aust Health Rev; 2020 Apr; 44(2):212-221. PubMed ID: 32241338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intramuscular versus enteral penicillin prophylaxis to prevent progression of rheumatic heart disease: Study protocol for a noninferiority randomized trial (the GOALIE trial).
    Rwebembera J; Ndagire E; Carvalho N; Webel AR; Sable C; Okello E; Sarnacki R; Spaziani AM; Mucunguzi A; Engelman D; Grobler A; Steer A; Beaton A
    Am Heart J; 2024 Sep; 275():74-85. PubMed ID: 38797460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RHD elimination: action needed beyond secondary prophylaxis.
    Hardie K; Ralph AP; de Dassel JL
    Aust N Z J Public Health; 2020 Oct; 44(5):427. PubMed ID: 32510810
    [No Abstract]   [Full Text] [Related]  

  • 12. Secondary prophylaxis for rheumatic fever: simple concepts, difficult delivery.
    Wilson N
    World J Pediatr Congenit Heart Surg; 2013 Oct; 4(4):380-4. PubMed ID: 24327631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary Prevention of Rheumatic Heart Disease in Nepal: Are We Going Backward?
    Regmi PR; Dhungel M; Kafle R
    JNMA J Nepal Med Assoc; 2022 Sep; 60(253):832-835. PubMed ID: 36705119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheumatic heart disease: progress and challenges in India.
    Shah B; Sharma M; Kumar R; Brahmadathan KN; Abraham VJ; Tandon R
    Indian J Pediatr; 2013 Mar; 80 Suppl 1():S77-86. PubMed ID: 22941214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinic factors associated with better delivery of secondary prophylaxis in acute rheumatic fever management.
    Quinn E; Girgis S; Van Buskirk J; Matthews V; Ward JE
    Aust J Gen Pract; 2019 Dec; 48(12):859-865. PubMed ID: 31774991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of secondary penicillin prophylaxis on valvular changes in patients with rheumatic heart disease in Far North Queensland.
    Haran S; Crane N; Kazi S; Axford-Haines L; White A
    Aust J Rural Health; 2018 Apr; 26(2):119-125. PubMed ID: 29168587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compliance of secondary prophylaxis for controlling rheumatic fever and rheumatic heart disease in a rural area of northern India.
    Kumar R; Thakur JS; Aggarwal A; Ganguly NK
    Indian Heart J; 1997; 49(3):282-8. PubMed ID: 9291651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penicillin Dried Blood Spot Assay for Use in Patients Receiving Intramuscular Benzathine Penicillin G and Other Penicillin Preparations To Prevent Rheumatic Fever.
    Page-Sharp M; Coward J; Moore BR; Salman S; Marshall L; Davis TME; Batty KT; Manning L
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A population pharmacokinetic study of benzathine benzylpenicillin G administration in children and adolescents with rheumatic heart disease: new insights for improved secondary prophylaxis strategies.
    Hand RM; Salman S; Newall N; Vine J; Page-Sharp M; Bowen AC; Gray K; Baker A; Kado J; Joseph J; Marsh J; Ramsay J; Sika-Paotonu D; Batty KT; Manning L; Carapetis J
    J Antimicrob Chemother; 2019 Jul; 74(7):1984-1991. PubMed ID: 30989171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seven key actions to eradicate rheumatic heart disease in Africa: the Addis Ababa communiqué.
    Watkins D; Zuhlke L; Engel M; Daniels R; Francis V; Shaboodien G; Kango M; Abul-Fadl A; Adeoye A; Ali S; Al-Kebsi M; Bode-Thomas F; Bukhman G; Damasceno A; Goshu DY; Elghamrawy A; Gitura B; Haileamlak A; Hailu A; Hugo-Hamman C; Justus S; Karthikeyan G; Kennedy N; Lwabi P; Mamo Y; Mntla P; Sutton C; Mocumbi AO; Mondo C; Mtaja A; Musuku J; Mucumbitsi J; Murango L; Nel G; Ogendo S; Ogola E; Ojji D; Olunuga TO; Redi MM; Rusingiza KE; Sani M; Sheta S; Shongwe S; van Dam J; Gamra H; Carapetis J; Lennon D; Mayosi BM
    Cardiovasc J Afr; 2016 May/Jun 23; 27(3):184-187. PubMed ID: 26815006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.